Revolution Genetics Inc.

According to Interface magazine (Corporate Review by Chris Hockabout), Revolution Genetics Inc. is an expanding genetic engineering firm dealing in genetic manipulation and biotechnology, headquartered in the Pangaean Arcology. It originated as the source of survival modifications for political refugees in Antarctica and went public soon after the Antarctican Collective did. (IN0003 p.15)

Key facts

  • Name comes from its political-revolution origins and the term “re-evolution”, the genetic restructuring of nature. Very open about its developments; confident of superiority; holds over 65% of current existing patents on genetic enhancements and biotechnology; less bureaucratic work structure. (IN0003 p.15)
  • Public face: Helix, an outlet like Chrome cybernetics stores dealing in biotech and minor genetic tailoring such as skin coloring and pheromone production. Helix was opened in mid-2020 as a smaller firm; 20 outlets: 7 in North America/Canada, 2 in the Collective, 8 in Europe, 1 in Hong Kong/China, 2 in Japan. (IN0003 p.15)
  • First appeared on the world market selling patents and with initial military contracts; its altered plants and food earned the Zimbabwe/Free South Africa contract to feed starving Africans. (IN0003 p.15)
  • Three major projects: a revolutionary chip design, biological memory storage for computers, and increased food production; releases start mid-2021; the latest contract renewal is January 1st, 2028. (IN0003 p.15)
  • Officers: President/CEO Magistrate Freianna VarTett (age 40, 36% primary stockholder); Executive VP/Chairman Stuart Tranell (32); EVP Helix Arthur Frost (37); EVP R&D Anna Karillian (30); VP security Americas Mayfair Joest (53); VP security Europe Jini Howden (26); Financial VP Kyle Schon (41); Secretary and Legal Council Rebecca T. Kanemoto (25). Auditors: Merrill, Asukaga & Finch. Security services: Arasaka Inc. (IN0003 p.15)
  • Night City regional office EVP: Trevor Ulrich. (IN0003 p.16)
  • Employees worldwide 35,000; troops 2000; covert 1075. (IN0003 p.15)
  • Revenue (million Euro Dollars; 2021 estimated): Genetics patents 720.4 / 1,145.7 / 2,209.5; Biotechnology 130.0 / 740.2 / 1,200.0; Nanotechnology - / 570.9 / 765.5; G.E. horticulture 200.7 / 706.7 / 1,000.5; Organic compounds 83.6 / 365.1 / 750.0; Biowar - / 450.2 / 660.0; Covert accounts - / 45.0 / 75.0; Total 1,134.7 / 4,003.8 / 6660.5 (years 2019/2020/2021). Growth 570% in 1 year; stock 220 Euro/share. (IN0003 p.15)
  • HQ: Chamber 1, Level 7, Prefix 33, Pangaean Arcology. Regional offices: Night City, New York, Berlin, Johannesburg, London, Hong Kong, Tokyo. (IN0003 p.15)
  • All regional offices have labs and operating rooms, one AV-4 assault vehicle, large security forces with Arasaka Inc. weapons, and a few genetically-enhanced combat personnel from Antarctica; six corporate jets and five Osprey IIs are split among offices. Major developments are done at the central Antarctic facility. An orbital facility purchase is planned within three years. Data Fortresses are Level 3 systems. (IN0003 p.15-16)
  • Rankings: 1st in Fortune 500 “New Corporations of 2020”; 74th Fortune Global Industrial Cos.; 32nd Business Today Sales 100; 100th Corporate Report 500. (IN0003 p.16)
  • Competition: Biotechnica, Biologic, Neil and Roman Pharmaceuticals, Petrochem, Chrome Company, NuSun Genetics. (IN0003 p.16)
  • Chief rival is Biotechnica; they are in a bidding war over research space at AquaDelphi. (IN0003 p.16)
  • Its datafortress icon exists in the Worldnet, in Megacity San Francisco and in Antarctica. (IN0003 p.16)
  • See Revolution Genetics Corporate War Report. (IN0003 p.16)

Relations

Contradictions / notes

  • Phone and fax lines are printed (1-999 numbers) but not recorded here. The article spells “Neil & Roman” while p.8 says “Neil-Roman”. (IN0003 p.15, p.8)
  • Stats checked against the page image (IN0003 p.15).

Sources

  • IN0003: Cyberpunk 2020 - Interface Magazine - Vol.1, Issue 3 (1991), PDF p. 8, 15-16